Christian H Møller

Summary

Affiliation: Copenhagen Trial Unit
Country: Denmark

Publications

  1. doi Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease
    Christian H Møller
    Department of Cardiothoracic Surgery, RT 2152, Copenhagen University Hospital, Rigshospitalet, Copenhagen
    Cochrane Database Syst Rev 3:CD007224. 2012
  2. doi Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Heart 97:907-13. 2011
  3. doi Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Cochrane Database Syst Rev 5:CD008817. 2013
  4. doi Graft patency after off-pump versus on-pump coronary artery surgery in high-risk patients
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Scand Cardiovasc J 44:161-7. 2010
  5. doi Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Eur Heart J 29:2601-16. 2008
  6. doi Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Cochrane Hepato Biliary Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Clin Pharmacol 66:1177-87. 2010
  7. doi Antibody induction therapy for lung transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, DK 2100
    Cochrane Database Syst Rev 11:CD008927. 2013
  8. doi Immunosuppressive T-cell antibody induction for heart transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, DK 2100
    Cochrane Database Syst Rev 12:CD008842. 2013
  9. doi Selective retrograde venous revascularization of the myocardium when PCI or CABG is impossible: investigation in a porcine model
    Christian H Møller
    Departments of Cardiothoracic Surgery, Copenhagen University Hospital, Copenhagen, Denmark
    Heart Surg Forum 11:E99-104. 2008
  10. doi Patient-prosthesis mismatch and reduction in left ventricular mass after aortic valve replacement
    Kristian Kandler
    Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Ann Thorac Surg 96:66-71. 2013

Detail Information

Publications14

  1. doi Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease
    Christian H Møller
    Department of Cardiothoracic Surgery, RT 2152, Copenhagen University Hospital, Rigshospitalet, Copenhagen
    Cochrane Database Syst Rev 3:CD007224. 2012
    ..Coronary artery bypass grafting (CABG) is performed both without and with cardiopulmonary bypass, referred to as off-pump and on-pump CABG respectively. However, the preferable technique is unclear...
  2. doi Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Heart 97:907-13. 2011
    ..To evaluate off-pump versus on-pump coronary artery bypass grafting (CABG) in patients with three-vessel disease and a high-risk operative profile...
  3. doi Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Cochrane Database Syst Rev 5:CD008817. 2013
    ..Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects...
  4. doi Graft patency after off-pump versus on-pump coronary artery surgery in high-risk patients
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Scand Cardiovasc J 44:161-7. 2010
    ..To compare angiographic graft patency in high-risk patients randomly allocated to off-pump vs. on-pump coronary artery bypass grafting (CABG)...
  5. doi Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses
    Christian H Møller
    Department of Cardio Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Eur Heart J 29:2601-16. 2008
    ..To assess the clinical outcomes of off- vs. on-pump coronary artery bypass surgery in randomized trials...
  6. doi Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Cochrane Hepato Biliary Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Clin Pharmacol 66:1177-87. 2010
    ..We conducted a systematic review of randomized trials to compare the benefits and harms of tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation...
  7. doi Antibody induction therapy for lung transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, DK 2100
    Cochrane Database Syst Rev 11:CD008927. 2013
    ..Consensus has not yet been achieved concerning use of immunosuppressive antibodies against T-cells for induction following lung transplantation...
  8. doi Immunosuppressive T-cell antibody induction for heart transplant recipients
    Luit Penninga
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, DK 2100
    Cochrane Database Syst Rev 12:CD008842. 2013
    ..To date, there is no consensus on the use of immunosuppressive antibodies against T-cells for induction after heart transplantation...
  9. doi Selective retrograde venous revascularization of the myocardium when PCI or CABG is impossible: investigation in a porcine model
    Christian H Møller
    Departments of Cardiothoracic Surgery, Copenhagen University Hospital, Copenhagen, Denmark
    Heart Surg Forum 11:E99-104. 2008
    ..No increase in lactate was observed. These results indicate that after LAD artery occlusion, CVBG can nourish the myocardium to a certain extent and prevent death in the majority of cases, although varying degrees of ischemia remain...
  10. doi Patient-prosthesis mismatch and reduction in left ventricular mass after aortic valve replacement
    Kristian Kandler
    Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark
    Ann Thorac Surg 96:66-71. 2013
    ..We examined the relationship between PPM and changes in left ventricular mass index at 3 months follow-up and also overall survival...
  11. doi Surgical treatment of acute pulmonary embolism--a 12-year retrospective analysis
    Per Lehnert
    Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark
    Scand Cardiovasc J 46:172-6. 2012
    ..Surgical embolectomy for acute pulmonary embolism (PE) is considered to be a high risk procedure and therefore a last treatment option. We wanted to evaluate the procedures role in modern treatment of acute PE...
  12. ncbi The Best Bypass Surgery Trial: rationale and design of a randomized clinical trial with blinded outcome assessment of conventional versus off-pump coronary artery bypass grafting
    Christian H Møller
    Department of Cardiothoracic Surgery, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Contemp Clin Trials 28:540-7. 2007
    ..Patients with a moderate- to high-risk of complications after CCAB may have additional benefit from OPCAB...
  13. ncbi Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study
    Marx Runge
    Department of Clinical Perfusion, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Extra Corpor Technol 41:10-4. 2009
    ..Individual patient managed anticoagulation during cardiac surgery using dose/response curve techniques based on in vitro analysis of heparin and protamine seems to reduce bleeding...
  14. doi Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials
    Christian H Møller
    Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    J Heart Lung Transplant 27:835-42. 2008
    ..Interleukin-2 receptor antagonists (IL-2Ras) are used increasingly for induction therapy. We conducted a systematic review of randomized trials assessing IL-2Ras...